Intestinal serotonergic vagal signaling as a mediator of microbiota-induced hypertension

Abstract

AbstractHypertension is a pervasive global health challenge, impacting over a billion individuals worldwide. Despite strides in therapeutic strategies, a significant proportion of patients remain resistant to the currently available therapies. While conventional treatments predominantly focus on cardiac, renal, and cerebral targets, emerging research underscores the pivotal role of the gut and its microbiota. Yet, the mechanisms governing interactions between the gut microbiota and the host blood pressure remain unclear. Here we describe a new neural mechanism of host-microbiota interaction, mediated by the intestinal serotonin (5-HT) signaling via vagal 5HT3a receptors, that is crucial for maintenance of blood pressure homeostasis. Notably, a marked decrease in both intestinal 5-HT and vagal 5HT3aR signaling is observed in hypertensive rats, and in rats subjected to fecal microbiota transplantation from hypertensive rats. Leveraging an intersectional genetic strategy in a Cre rat line, we demonstrate that intestinal 5HT3aR vagal signaling is a crucial link between the gut microbiota and blood pressure homeostasis and that recovery of 5-HT signaling in colon innervating vagal neurons can alleviate hypertension. This paradigm-shifting finding enhances our comprehension of hypertensive pathophysiology and unveils a promising new gut-brain axis mechanism as a potential therapeutic target for combating resistant hypertension associated with gut dysbiosis.